AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
The investment will catalyse various components of the IndiaAI Mission
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
BHL will undertake the development and supply of these molecules
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The facility will accommodate over 1,500 employees
Subscribe To Our Newsletter & Stay Updated